News
UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...
A research team at the University of Cologne has made a significant breakthrough in understanding the role of the tau protein in Alzheimer's disease. Using human induced pluripotent stem cells ...
Adults with a father who had Alzheimer’s showed greater tau buildup, a key marker of the disease. Women in the study had more ...
Breakthrough as two FDA-approved drugs are found to reverse Alzheimer’s — including restoring memory
Researchers have found that a pair of drugs can not only slow down Alzheimer’s disease but actually reverse it and restore memory in mice.
Alzheimer’s disease, a devastating neurodegenerative disorder, is closely linked to the accumulation of tau protein in the brain. When tau becomes hyperphosphorylated, it forms neurofibrillary ...
14d
News-Medical.Net on MSNUNM researchers get $1 million grant to launch early clinical trial for Alzheimer’s vaccineUniversity of New Mexico researchers have received funding to launch an early-stage clinical trial of a vaccine engineered to clear pathological tau protein from the brains of patients suffering from ...
Feb 20, 2022 3:52 pm · Updated Feb 21, 2022 11:12 am ...
A protein long blamed for the brain damage seen in Alzheimer's disease has now been found in astonishingly high levels in healthy newborn babies, challenging decades of medical dogma.
The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage a toxic buildup of protein, which can contribute to Alzheimer’s and related ...
Tau protein in Alzheimer's disease Alzheimer’s Disease (AD) is the most prevalent neurodegenerative disorder among the elderly, marked by abnormal Tau phosphorylation.
A research team at the University of Cologne has made a significant breakthrough in understanding the role of the tau protein in Alzheimer's disease. Using human induced pluripotent stem cells (iPSCs) ...
Years before neurofibrillary tangles (NFTs) of tau protein show up in brain scans of patients with Alzheimer’s disease (AD), a biomarker test developed at the University of Pittsburgh School of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results